RODNEY HUFF: Open Payments
NPI 1205870490 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,080 in 59 payments from 25 companies in 2025. Trend: 2023 $1,743 · 2024 $890 · 2025 $3,080
Food & beverage: $2,218Consulting: $750Education: $112
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $922 |
| Gilead Sciences, Inc. | 9 | $358 |
| AstraZeneca Pharmaceuticals LP | 6 | $301 |
| Amgen Inc. | 2 | $186 |
| Janssen Biotech, Inc. | 4 | $171 |
| Immunocore Limited | 2 | $144 |
| E.R. Squibb & Sons, L.L.C. | 1 | $130 |
| Lilly USA, LLC | 3 | $125 |
| Smith+Nephew, Inc. | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
Products named: DATROWAY, Trodelvy, IMDELLTRA (AMG757), RYBREVANT, KIMMTRAK, OPDIVO, GRAFIX PL, NINLARO.
Industry payments across VA — which companies pay providers there.
